Financial Penalties Imposed on Large Pharmaceutical Firms for Illegal Activities.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 33201196.
- Also identified by DOI 10.1001/jama.2020.18740 and PMC identifier PMC7672515.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study describes financial penalties levied on pharmaceutical companies for illegal activities by type of activity and dollar value between 2003 and 2016.